Stockinder
Jarvis is thinking
Send
Stockinder
Jarvis is thinking
Send
EIKN Financials — Stockinder
← Eikon Therapeutics, Inc.
Financials
EIKN · NasdaqGS
Income Statement
2025-12-31
2024-12-31
Revenue
Total money the company brought in from its core business during the period, before any costs are subtracted.
$0
$0
Net Income
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.
-$333.64M
-$243.81M
Search the Web for These Figures 🔍